Skip to main content
TVTX filings

Corporate insider profile

Sandra Calvin Filing Activity

Latest reported as SVP, CHIEF ACCOUNTING OFFICER of Travere Therapeutics, Inc. (TVTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$902,595.39
Latest transaction
Apr 14, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 14, 2026Travere Therapeutics, Inc. (TVTX)SVP, CHIEF ACCOUNTING OFFICERSale21,977$41.07$902,595